Vorschau! Die Detailseite für diese Publikation wurde nicht aktiviert!
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy
more| Titel | COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy |
|---|---|
| Medien | European Respiratory Journal |
| Verfasser | Markus Weckmann, Thomas Bahmer, Jannie Sand, Sarah Ronnow, Martin Pech, Cornelis Vermeulen, Alen Faiz, Diana Leeming, Morten Karsdal, Lars Lunding, Brian Oliver, Michael Wegmann, Gudrun Ulrich-Merzenich, Uwe Juergens, Jannis Duhn, Yves Laumonnier, Olga Danov, Katherina Sewald, Ulrich Zissler, Marnix Jonker, Inke Koenig, Gesine Hansen, Erika von Mutius, Oliver Fuchs, Anna-Maria Dittrich, Bianca Schaub, Christine Happle, Klaus Rabe, Maarten van de Berge, Janette Burgess, Matthias Kopp, Prof. Dr. Ulrich Zißler |
| Veröffentlichungsdatum | 2021-06-29 |
| Zitation | Weckmann, Markus; Bahmer, Thomas; Sand, Jannie; Ronnow, Sarah; Pech, Martin; Vermeulen, Cornelis; Faiz, Alen; Leeming, Diana; Karsdal, Morten; Lunding, Lars; Oliver, Brian; Wegmann, Michael; Ulrich-Merzenich, Gudrun; Juergens, Uwe; Duhn, Jannis; Laumonnier, Yves; Danov, Olga; Sewald, Katherina; Zissler, Ulrich; Jonker, Marnix; Koenig, Inke; Hansen, Gesine; von Mutius, Erika; Fuchs, Oliver; Dittrich, Anna-Maria; Schaub, Bianca; Happle, Christine; Rabe, Klaus; van de Berge, Maarten; Burgess, Janette; Kopp, Matthias; Zißler, Ulrich (2021): COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. European Respiratory Journal. DOI: 10.1183/13993003.03969-2020. |